DermaSensor forges partnerships to advance its skin cancer detection tech

DermaSensor today announced four new partnerships to accelerate growth of its skin-cancer-detecting device.

Earlier this year, the Miami-based company received FDA clearance for DermaSensor, its AI-powered, non-invasive scanner that provides physicians with immediate risk assessments of lesions suggestive of melanoma, basal cell carcinoma and squamous cell carcinoma.

Device use reduces missed skin cancer referrals by more than 50% with over 100 primary care physicians. FDA studies also found it to demonstrate 96% device sensitivity with more than 1,000 patients.

Read full article: https://www.massdevice.com/dermasensor-forges-partnerships-to-advance-its-skin-cancer-detection-tech/